CanniMed To Aurora Cannabis: No Means No

CanniMed Therapeutics (CMMDF)has made it clear that it does not want to be acquired by Aurora Cannabis (ACBFF). The company announced that it has applied to the Financial and Consumer Affairs Authority of Saskatchewan and the Ontario Securities Commission for help regarding the hostile takeover.

CanniMed said that Aurora’s offer should be considered an “insider bid” for the purposes of applicable Canadian securities laws. They claim that SaskWorks Venture Fund Inc., Apex Investments Limited Partnership, Golden Opportunities Fund Inc. and Vantage Asset Management Inc. (locked-up shareholders) are all working with Aurora. Stating, “The CanniMed Shares of the Locked-Up Shareholders be excluded from the 50 per cent minimum tender condition contained in section 2.29.1(c) of National Instrument 62-104 – Take-Over Bids and Issuer Bids”

CanniMed is also asking the following from the regulators:

  • The Hostile Bid is an “insider bid” for purposes of MI 61-101 and consequently, Aurora be required to obtain a formal valuation in connection with the Hostile Bid and otherwise comply with the requirements in Part 2 of MI 61-101;
  • The Hostile Bid be cease-traded until 105 days after a take-over bid circular that complies with the rules for an “insider bid” as required by MI 61-101, is delivered to the CanniMed Shareholders;
  • Aurora is required to retract and correct several materially false and misleading statements in connection with the Hostile Bid; and
  • Each of the Locked-Up Shareholders failed to issue news releases and file Early Warning Reports as required by Part 5 of NI 62-104 and Part 3 of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

Aurora made an offer to acquire CanniMed on November 13, 2017, in a C$582 million ($453 million) offer. CanniMed is instead urging shareholders to reject that deal and support its proposed acquisition of Newstrike Resources Ltd., a marijuana firm backed by the Tragically Hip.

The two companies have been at odds over the proposed acquisition. Aurora says it made a formal offer, while CanniMed disagrees and said no formal offer was ever made. While the two were arguing publicly over the proposed offer, CanniMed moved forward with Newstrike. CanniMed also began putting poison pills in place to sour Aurora’s desire to takeover the company. In a company statement CanniMed said, “By approving the Newstrike Acquisition, CanniMed Shareholders can create a premier cannabis company that is positioned to offer innovative, high-quality products with two distinct top-tier brands that are each well-positioned to address key product trends and emerging drivers of growth in both the medical and adult use recreational cannabis markets. Taking this step will make CanniMed more valuable to any future acquiror.”

CanniMed went on to note that Aurora has had two product recalls in less than a year and its Aurora Sky is delayed with increasing costs. The company also suggested that Aurora’s management sold stock ahead of a stock decline and that it had an “aggressive and unfocused acquisition strategy.” CanniMed also said that the Aurora offer is tilted in favor of their shareholders.

Aurora Fires Back

Aurora said it wasn’t even looking for such a deal, but that some of CanniMed’s shareholders approached them. “This is the latest in a series of increasingly desperate schemes by CanniMed management that would have the effect of disenfranchising their own shareholders and preventing them from exercising their fundamental rights,” said Terry Booth, CEO of Aurora. “We made a bona fide offer, featuring a compelling premium that 38% of existing CanniMed shareholders immediately supported and continue to support through lockup agreements, including two prominent Saskatchewan -based investment funds. We had hoped to make this a friendly and collaborative process, but Mr. Zettl refuses to even pick up the phone or return our calls to have a discussion.”

Debra Borchardt

Debra BorchardtDebra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


9 comments

  • Sherry

    December 11, 2017 at 5:45 pm

    I can only see the desperation in these actions they are taking. How pathetic is this, CannieMed?

    Reply

  • Frank Farkas

    December 12, 2017 at 12:39 pm

    Looks & feels to me more like self serving actions by senior management of Canni-med, looking after their own interests, rather than the interests of the shareholders

    Reply

  • Michael Franklin

    December 12, 2017 at 1:32 pm

    Good afternoon….your reporting work is fine quality.
    May I please ask if all portions of the Cannimeds requests were uniformly dismissed or ruled upon by the
    Securities Authority, Did they separate any of the rulings with Aurora. Thank you. Michael Frankln

    Reply

    • Debra Borchardt
      Debra Borchardt

      December 12, 2017 at 3:47 pm

      In an Aurora Cannabis statement, the company said, “The Star Phoenix reported that the Government of Saskatchewan rejected the CanniMed CEO’s gambit, with a spokesperson stating that the Ministry of Economy “views this strictly as a commercial transaction, and will not be commenting further.”

      Reply

      • Michael Franklin

        December 12, 2017 at 8:08 pm

        Thx for getting back….

        Reply

        • Debra Borchardt
          Debra Borchardt

          December 13, 2017 at 9:16 am

          We updated the story to reflect that the Ontario Securities Commission on Tuesday scheduled a hearing on CanniMed Therapeutics on Dec. 20.

          Reply

  • Jeffrey Michael III

    January 12, 2018 at 1:48 pm

    It is crystal clear CanniMed officials are trying to keep something hidden from the public which I am sure will come to fruition once the step inside the CanniMed doors and look up under the hood. A NewStrike deal looks just crazy when you glance at their books. So, this just tells me that upper management and officials are hiding something from the public. No reason to take such a nice offer from Aurora and become one of the leading marijuana producers in Canada! All they are doing now is reaching and demeaning Aurora at any possible time. The Securities and Exchange commission will catch on to this coming up on the 20th of this month, January!

    Reply

    • Debra Borchardt
      Debra Borchardt

      January 12, 2018 at 8:00 pm

      It does seem like there is more than meets the eye.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 6 hours

$CGC ⁦@CanopyRiversInc⁩ great panel last week at the

@GreenMarketRpt – 6 hours

The good and bad on $TLRY this week.

@GreenMarketRpt – 1 day

Ready to talk $TLRY ⁦@WallandBroad⁩ on ⁦@cheddar⁩

Back to Top

You have Successfully Subscribed!